Compare Becton Dickinson and Co (BDX) vs YieldMax MSTR Option Income Strategy ETF (MSTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs YieldMax MSTR Option Income Strategy ETF — how do they compare? Becton Dickinson and Co trades at $180.66 (market cap $49.41B), while YieldMax MSTR Option Income Strategy ETF trades at $12.35. The key difference: Becton Dickinson and Co pays a 2.32% dividend while YieldMax MSTR Option Income Strategy ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| BDX | MSTY | |
|---|---|---|
Market Cap | $49.41B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $185.39 | $95.95 |
52-Week Low | $138.62 | $11.55 |
Enterprise Value | $65.51B | — |
Dividend Yield | 2.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $179.63, up 1.57% with a bullish technical outlook supported by moving averages. The company reported strong Q3 2026 earnings, beating estimates with $3.23 EPS versus $3.14 expected, and raised full-year guidance. Revenue growth remains steady at 4.4% FX-neutral, though margins face pressure from tariffs. Analysts maintain a mixed consensus with 47% buy ratings and a $183 price target, suggesting modest upside from current levels.
The stock presents a balanced opportunity with solid fundamentals and dividend stability, but faces headwinds from margin compression and competitive pressures. Near-term catalysts include continued execution on growth initiatives, while risks include tariff impacts and healthcare regulatory changes. The current valuation at 31.39 P/E appears fair given growth prospects.
MSTY trades at $12.45, down 0.8% on the day, with a bearish technical outlook showing 16 sell signals versus 1 buy signal. The ETF has experienced significant price erosion, with recent articles indicating a 67.45% decline in fund value while continuing weekly distributions. Support and resistance levels cluster tightly around $12-$13, indicating limited near-term price movement potential.
The outlook remains challenging as MSTY faces structural issues with its covered-call strategy capping upside while exposing investors to full downside risk. High distribution yields mask underlying NAV erosion, creating tax complications for investors. Continued pressure on the underlying Strategy (MSTR) position and Bitcoin volatility present ongoing headwinds for recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About YieldMax MSTR Option Income Strategy ETF
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →
